This test is most useful if any of these apply to you.
Two women can both have a vagina full of Lactobacillus and still face very different risks. The species matters. If your dominant Lactobacillus is L. iners (Lactobacillus iners) rather than L. crispatus, your microbiome is more likely to drift into bacterial vaginosis, harbor Candida, allow chlamydia to take hold, or shift in ways that can raise the risk of preterm birth in some populations.
A vaginal swab test that quantifies L. iners tells you which kind of Lactobacillus-dominated state you are in. That single distinction reframes the picture for women trying to conceive, planning a pregnancy, dealing with recurrent infections, or simply trying to understand a reproductive health story that standard panels miss.
L. iners is one of the most common bacteria in the reproductive-age vagina, detected in a majority of samples in molecular panels. It produces lactic acid but, unlike L. crispatus, it makes only limited amounts of hydrogen peroxide and lacks D-lactic acid production. That biochemistry translates into weaker pathogen inhibition and a less stable community. Researchers describe L. iners as a transitional species that thrives in disturbed ecosystems and can flip more easily between healthy and dysbiotic states.
A high L. iners signal generally means your vaginal environment is dominated by a Lactobacillus that offers less protection than L. crispatus and is more prone to instability. A low L. iners signal alongside high L. crispatus or high total Lactobacillus usually indicates a more robust ecosystem. L. iners that is high within a broadly disturbed community is a marker of transition or recovery rather than protection.
L. iners often sits at both ends of a bacterial vaginosis (BV) episode. It commonly dominates before BV develops, persists during dysbiosis when other Lactobacilli have been wiped out, and is frequently the species that repopulates the vagina after metronidazole. A meta-analysis comparing L. iners-dominated and L. crispatus-dominated states reported a roughly 2.1-fold higher prevalence of BV in the L. iners group, though the confidence interval crossed 1.0, so this trend was not statistically significant.
There is a counterintuitive twist worth understanding. In one study of 541 women, higher pre-treatment L. iners was associated with better BV cure rates after metronidazole, and some L. iners strains directly inhibited Gardnerella vaginalis in laboratory tests. This is not a contradiction. L. iners is not a simple good-versus-bad number. It is a phenotype indicator. A community where L. iners is the last remaining Lactobacillus may help maintain enough acid environment to support antibiotic recovery, even while that same community is more vulnerable to dysbiosis returning.
Vaginal microbiota dominated by L. iners has been linked to higher susceptibility to Chlamydia trachomatis. A 2023 meta-analysis pooling six studies found that L. iners-dominated communities were associated with about 3.4 times higher odds of chlamydia infection compared with L. crispatus-dominated ones. The Dutch case-control study of 122 women that contributed to this pooled estimate found a smaller individual effect (odds ratio about 2.6), illustrating how the relationship looks across different populations.
Research in younger South African women has also shown that less stable, non-L. crispatus communities, including L. iners-rich states, correlate with greater HIV susceptibility at a community level. L. iners on its own does not cause infection, but it identifies an ecosystem where pathogens face less resistance.
L. iners is among the most studied vaginal bacteria in pregnancy. Early dominance has been linked to higher rates of recurrent spontaneous preterm birth in a prospective cohort of 152 women, and a separate study of 111 healthy pregnant women found that L. iners alone as the dominant Lactobacillus in early pregnancy was associated with later preterm delivery. The picture is not uniform across all populations, however. A 2024 systematic review and meta-analysis found that L. iners dominance was actually associated with lower preterm birth risk in some pooled analyses, so the relationship appears to be population- and context-dependent.
Across studies, L. iners-dominant pregnancies are more likely to transition to non-Lactobacillus states as gestation progresses, which is the broader pattern linked to preterm birth risk. A study in Chinese healthy pregnant women found that L. iners may help maintain ecosystem stability in some populations, so the species-by-context interaction is real.
In a study of 255 reproductive-age women, L. iners-dominant microbiomes were about three times more likely to harbor Candida than L. crispatus-dominant ones. A separate study of 93 pregnant women showed that persistent group B Streptococcus (GBS) colonization throughout pregnancy was tied to higher L. iners and lower L. crispatus abundance. A culture-based study of 1,860 women in the third trimester showed that L. crispatus, but not L. iners, was inversely associated with GBS.
In a study of 88 women undergoing assisted reproductive technology, cervical microbiomes higher in L. crispatus and lower in L. iners were associated with more favorable pregnancy outcomes. In a separate study of 125 cervical cancer patients receiving chemoradiotherapy, L. iners abundance before treatment was identified as a potential biomarker of recurrence.
The vaginal microbiome is dynamic. Composition shifts across the menstrual cycle, with sexual activity, contraception, pregnancy, postpartum recovery, antibiotics, and probiotics. A single L. iners reading captures a moment, not a trajectory. What matters most is the pattern. Is L. iners stable as the dominant species, or is it the species that takes over when others fall away?
Get a baseline, then retest at 3 to 6 months if you are changing anything that affects the vaginal environment, such as starting probiotics, completing BV treatment, planning pregnancy, or switching contraception. After that, annual testing is reasonable. If you are actively trying to conceive, are pregnant, or recovering from recurrent infections, more frequent monitoring helps you see whether your community is drifting toward an L. crispatus-rich state or settling into a less protective L. iners-dominated one.
Several common factors can distort a single L. iners reading. Knowing what they are helps you avoid misinterpreting your result.
If your swab shows high L. iners and low L. crispatus, the most useful next step is to look at the broader picture rather than chase the single number. Pair this result with a full vaginal microbiome panel that quantifies L. crispatus, L. gasseri, L. jensenii, Gardnerella vaginalis, Atopobium vaginae, Candida species, and pH. Together these tell you whether your community is L. iners-dominant in a Lactobacillus-rich way, sitting in a transitional state, or trending toward overt dysbiosis.
If you have symptoms, recurrent BV, recurrent yeast, fertility concerns, or a history of preterm birth, share these results with a gynecologist who works with microbiome-informed care. If you are planning pregnancy, addressing an L. iners-dominant state before conception is a reasonable goal, though specific interventions to reliably shift L. iners are still being studied and no FDA-approved therapy specifically targets L. iners replacement. If you are pregnant and the result shows early L. iners dominance, a maternal-fetal medicine specialist can help integrate this signal with cervical length and other risk markers.
Because L. iners is a research-grade marker without standardized clinical cutpoints, the most useful approach is comparative rather than absolute. Look at the ratio of L. crispatus to L. iners in your result. A community heavy in L. crispatus with low L. iners is generally favorable. A community heavy in L. iners with little L. crispatus is the pattern most consistently linked to higher risks in many studies. A community where neither dominates and BV-associated bacteria are creeping in is the pattern most likely to need attention.
Evidence-backed interventions that affect your Lactobacillus Iners level
Lactobacillus Iners is best interpreted alongside these tests.
Lactobacillus Iners is included in these pre-built panels.